Jia et al.
chromatography was repeated to obtain a colorless solid, mp 62-64
°C. The spectral data were as follows: 1H NMR (CDCl3) δ 3.42 (s,
3H), 3.90 (s, 3H), 4.95 (s, 2H), 5.18 (s, 1H), 5.49 (s, 1H), 7.24 (d,
J ) 8.0 Hz, 2H), 7.47 (d, J ) 7.8 Hz, 2H), 7.59 (t, J ) 7.8 Hz,
1H), 7.95 (d, J ) 8 0.0 Hz, 2H), 8.05 (d, J ) 7.8 Hz, 2H); 13C
NMR (CDCl3) 37.9, 52.5, 65.0, 123.2, 126.4, 128.7, 129.8, 129.9,
130.3, 130.9, 133.5, 139.1, 148.5, 166.1, 166.4, 168.9. Anal. Calcd
for C20H19NO5: C, 67.98%; H, 5.42%; N, 3.96%. Found: C, 67.93%;
H, 5.52%; N, 4.13%.
Preparation of Methyl 3-[(Benzoyloxy)methyl]-1-methyl-2-
oxo-1,2,3,4-tetrahydroquinoline-6-carboxylate (6a, LG- ) Ph-
COO-). To a solution of 0.19 g (0.78 mmol) of 6a (LG- ) HO-)
and 0.15 mL of triethylamine in 10 mL of CH2Cl2 at 0 °C was
added, dropwise with stirring, 0.11 mL (0.78 mmol) of benzoyl
chloride in 10 mL of CH2Cl2. The reaction was stirred overnight
at room temperature. The reaction mixture was washed with 5%
NaHCO3 and brine. After drying over Na2SO4, the solvent was
removed in vacuo and the residue was chromatographed on silica
gel, eluting with 10% ethyl acetate in hexane, to obtain 0.23 g (0.65
mmol, 84% yield) of colorless crystalline product, mp 127-131
°C. The spectral data were as follows: 1H NMR (CDCl3) δ
2.98-3.16 (br m, 3H), 3.40 (s, 3H), 3.88 (s, 3H), 4.57 (dd, J )
6.15, 11.1 Hz, 1H), 4.77 (dd, J ) 3.81, 11.1 Hz, 1H), 7.01 (d, J )
8.52 Hz, 1H), 7.41 (t, J ) 7.8 Hz, 2H), 7.54 (t, J ) 7.8 Hz, 1H),
7.87 (s, 1H), 7.97-7.93 (m, 3H); 13C NMR (CDCl3) 28.7, 30.2,
40.2, 52.3, 63.9, 114.6, 124.8, 124.8, 128.6, 129.5, 129.8, 130.0,
133.3, 144.1, 166.5, 166.6, 169.7. Anal. Calcd for C20H19NO5: C,
67.98%; H, 5.42%; N, 3.96%. Found: C, 68.06%; H, 5.58%; N,
3.99%.
to that reported previously.17 To a solution of 1.0 g (4.0 mmol) of
4a (LG- ) HO-), 0.57 g (6.0 mmol) of phenol, and 1.3 g (4.81
mmol) of PPh3 in 20 mL of dry THF was added 0.76 mL (4.8
mmol) of diethyl azodicarboxylate dropwise at 0 °C under N2. The
reaction mixture was then stirred at room temperature for 24 h and
was concentrated in vacuo. The residue was chromatographed on
silica gel, eluting with 10% ethyl acetate in hexane, to give 0.52 g
(1.6 mmol, 40%) of NMR pure 4a (LG- ) PhO-) as a colorless
oil. The spectral data were as follows: 1H NMR (CDCl3) δ 3.42 (s,
3H), 3.91 (s, 3H), 4.67 (s, 2H), 5.09 (s, 1H), 5.44 (s, 1H), 6.91 (d,
J ) 8.8 Hz, 2H), 6.96 (t, J ) 7.4 Hz, 1H), 7.30 (m, 4H), 7.98 (d,
J ) 8.8 Hz, 2H); 13C NMR (CDCl3) 37.8, 52.5, 68.7, 114.9, 121.4,
121.9, 126.6, 128.7, 129.7, 130.9, 140.0, 148.7, 158.5, 166.5, 169.3.
Anal. Calcd for C19H19NO4: C, 70.14%; H, 5.89%; N, 4.30%.
Found: C, 69.96%; H, 5.85%; N, 4.37%.
Preparation of Methyl 1-Methyl-2-oxo-3-(phenoxymethyl)-
1,2,3,4-tetrahydroquinoline-6-carboxylate (6a, LG- ) PhO-).
A solution of 0.23 g (0.71 mmol) of 4a (LG- ) PhO-) in N2
saturated 250 mL of benzene containing several crystals of
p-methoxyphenol as a radical inhibitor was irradiated with a 450
W Hanovia medium pressure mercury lamp in an immersion well
apparatus for 8 h with stirring. The solvent was removed in vacuo,
and the residue was chromatographed on silica gel, eluting with
10% ethyl acetate in hexane, to give 0.16 g (0.49 mmol, 69% yield)
of 6a (LG- ) PhO-) as a colorless crystals, mp 161-164 °C. The
spectral data were as follows: 1H NMR (CDCl3) δ 3.01-3.06 (m,
2H), 3.24 (dd, J ) 9.96, 21.3 Hz, 1H), 3.42 (s, 3H), 3.91 (s, 3H),
4.19 (dd, J ) 2.94, 9.42 Hz, 1H), 4.49 (dd, J ) 2.94, 9.42 Hz,
1H), 6.92-7.05 (m, 3H), 7.29 (t, J ) 7.47 Hz, 2H), 7.92 (s, 1H),
7.98 (dd, J ) 1.92, 8.46 Hz, 1H); 13C NMR (CDCl3) 28.7, 30.2,
40.7, 52.3, 66.8, 114.6, 114.8, 121.3, 124.9, 125.3, 129.7, 129.8,
129.9, 144.2, 158.8, 166.8, 170.2.
Preparation of Methyl 4-[{2-[(Phenylacetyloxy)methyl]acry-
loyl}(methyl)amino]benzoate (4a, LG- ) PhCH2COO-). To a
solution of 1.0 g (4.0 mmol) of 4a (LG- ) HO-) and 0.56 mL of
triethylamine in 10 mL of CH2Cl2 at 0 °C was added, dropwise
with stirring, 0.56 mL (4.2 mmol) of phenylacetyl chloride in 10
mL of CH2Cl2. The reaction was stirred overnight at room
temperature. The reaction mixture was washed with 5% NaHCO3
and brine. After drying over Na2SO4, the solvent was removed in
vacuo, and the residue was chromatographed on silica gel, eluting
with 10% ethyl acetate in hexane to obtain 1.4 g (3.8 mmol, 95%
yield) of NMR pure 4a (LG- ) PhCH2COO-) as a colorless oil.
Preparation of Methyl 4-[{2-[(Bocalanyloxy)methyl]acryloyl}-
(methyl)amino]benzoate (4a, LG- ) BocAla). To a solution of
1.0 g (4.0 mmol) of 4a (LG- ) HO-), 0.76 g (4.0 mmol) BocAla,
and a tiny bit of DMAP in 20 mL of CH2Cl2 was added 0.83 g
(4.0 mmol) of DCC at room temperature. The reaction mixture was
stirred at room temperature for 24 h and concentrated in vacuo.
Ether was added, the mixture was filtered, and the filtrate was
concentrated in vacuo. The residue was chromatographed on silica
gel eluting with 20% of ethyl acetate in hexane, to give 1.32 g (3.1
mmol, yield 78%) of 4a (LG- ) BocAla) as colorless needles, mp
1
The spectral data were as follows: H NMR (CDCl3) δ 3.27 (s,
3H), 3.62 (s, 2H), 3.85 (s, 3H), 4.63 (s, 2H), 4.97 (s, 1H), 5.22 (s,
1H), 6.95 (d, J ) 7.2 Hz, 2H), 7.19-7.28 (m, 5H), 7.84 (d, J )
7.2 Hz, 2H); 13C NMR (CDCl3) 37.8, 41.6, 52.5, 65.4, 126.4, 127.5,
128.7, 128.9, 128.9, 129.6, 130.9, 133.9, 138.9, 148.4, 166.4, 168.6,
170.9. Anal. Calcd for C21H21NO5: C, 68.65%; H, 5.76%; N, 3.81%.
Found: C, 68.44%; H, 5.82%; N, 4.00%.
1
95-96 °C. The spectral data were as follows: H NMR (CD3CN)
δ 1.31 (d, J ) 7.32 Hz, 3H), 1.37 (s, 9H), 3.32 (s, 3H), 3.85 (s,
3H), 4.19 (br, 1H), 4.68 (s, 2H), 5.08 (s, 1H), 5.36 (s, 1H),
5.71-5.74 (br, 1H), 7.36 (d, J ) 8.82 Hz, 2H), 7.98 (d, J ) 8.82
Hz, 2H); 13C NMR (CDCl3) 17.8, 28.4, 37.8, 50.2, 52.7, 65.6, 79.8,
122.4, 127.6, 129.2, 131.2, 140.1, 149.5, 156.3, 166.9, 169.0, 173.6.
Anal. Calcd for C21H28N2O7: C, 59.99%; H, 6.71%; N, 6.66%.
Found: C, 60.18%; H, 6.68%; N, 6.79%.
Preparation of Methyl 1-Methyl-2-oxo-3-(phenylacetyloxy-
methyl)-1,2,3,4-tetrahydroquinoline-6-carboxylate (6a, LG-
)
)
PhCH2COO-). To a solution of 0.25 g (1.0 mmol) of 6a (LG-
HO-) and 0.14 mL of triethylamine in 10 mL of CH2Cl2 at 0 °C
was added, dropwise with stirring, 0.14 mL (1.1 mmol) of
phenylacetyl chloride in 5 mL of CH2Cl2. The reaction was stirred
overnight at room temperature. The reaction mixture was washed
with 5% NaHCO3 and brine. After drying over Na2SO4, the solvent
was removed in vacuo, and the residue was purified on silica gel,
eluting with 10% ethyl acetate in hexane on silica gel to obtain
0.32 g (0.87 mmol, 87% yield) of colorless crystalline product,
mp 48-51 °C. The spectral data were as follows: 1H NMR (CDCl3)
δ 2.78-2.93 (br m, 3H), 3.37 (s, 3H), 3.62 (s, 2H), 3.92 (s, 3H),
4.33 (dd, J ) 6.12, 11.22 Hz, 1H), 4.56 (dd, J ) 4.08, 11.22 Hz,
1H), 7.00 (d, J ) 8.40 Hz, 1H), 7.26-7.34 (m, 5H), 7.78 (s, 1H),
7.95 (dd, J ) 2.01, 8.04 Hz, 1H); 13C NMR (CDCl3) 28.3, 30.1,
40.0, 41.4, 52.5, 63.5, 114.5, 124.8, 127.4, 128.8, 129.4, 129.4,
129.4, 129.7, 134.0, 144.0, 166.6, 169.6, 171.5. Anal. Calcd for
C21H21NO5: C, 68.65%; H, 5.76%; N, 3.81%. Found: C, 68.86%;
H, 5.74%; N, 3.77%.
Preparation of Methyl 3-[(Bocalanyloxy)methyl]-1-methyl-
2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylate (6a, LG-
)
BocAla). To a solution of 0.19 g (0.78 mmol) of 6a (LG- ) HO-),
0.16 g (0.82 mmol) of BocAla, and a bit of DMAP in 20 mL of
CH2Cl2 was added 0.19 g (0.94 mmol) of DCC at room temperature.
The reaction mixture was stirred at room temperature for 24 h and
concentrated in vacuo. Ether was added, the mixture was filtered,
and the filtrate was concentrated in vacuo. The residue was
chromatographed on silica gel, eluting with 20% of ethyl acetate
in hexane, to give 0.26 g (0.62 mmol, yield 79%) of 6a (LG-
)
BocAla) as colorless needles, mp 110-115 °C. The spectral data
1
were as follows: H NMR (CDCl3) δ 1.31 (d, J ) 7.2 Hz, 3H),
1.41 (s, 9H), 2.90-3.11 (m, 3H), 3.34 (s, 3H), 3.86 (s, 3H), 4.13
(t, J ) 7.0 Hz, 1H), 4.31-4.52 (m, 2H), 5.66 (br, s, 1H), 7.13 (d,
J ) 8.5 Hz, 1H), 7.84 (s, 1H), 7.92 (dd, J ) 1.9, 8.5 Hz, 1H); 13
C
NMR (CDCl3) δ 1.31 (d, J ) 7.32 Hz, 3H), 1.37 (s, 9H), 3.32 (s,
3H), 3.85 (s, 3H), 4.19 (br, 1H), 4.68 (s, 2H), 5.08 (s, 1H), 5.36 (s,
1H), 5.71-5.74 (br, 1H), 7.36 (d, J ) 8.82 Hz, 2H), 7.98 (d, J )
8.82 Hz, 2H); 13C NMR (CDCl3) 17.7, 28.4, 30.1, 40.3, 40.4, 50.3,
Preparation of Methyl 4-{methyl[2-(phenoxymethyl)acryl-
oyl]amino}benzoate (4a, LG- ) PhO-). The procedure is similar
8876 J. Org. Chem. Vol. 73, No. 22, 2008